Filing Details
- Accession Number:
- 0001179110-10-000586
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-06 12:00:00
- Reporting Period:
- 2010-01-04
- Filing Date:
- 2010-01-06
- Accepted Time:
- 2010-01-06 15:53:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820237 | Gen Probe Inc | GPRO | Surgical & Medical Instruments & Apparatus (3841) | 330044608 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1230317 | L Daniel Kacian | Gen-Probe Incorporated 10210 Genetic Center Drive San Diego CA 92121 | Exec. Vp, Chief Scientist | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-01-04 | 24,251 | $12.29 | 61,015 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-01-04 | 36,749 | $13.66 | 97,764 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-01-04 | 70,000 | $29.53 | 167,764 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-01-04 | 88,928 | $43.01 | 78,836 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-01-04 | 9,544 | $0.00 | 9,544 | $12.29 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-01-04 | 14,707 | $0.00 | 14,707 | $12.29 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-01-04 | 36,749 | $0.00 | 36,749 | $13.66 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-01-04 | 70,000 | $0.00 | 70,000 | $29.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-09-01 | No | 4 | M | Direct | |
| 0 | 2012-06-01 | No | 4 | M | Direct | |
| 0 | 2010-08-17 | No | 4 | M | Direct | |
| 0 | 2013-08-15 | No | 4 | M | Direct |
Footnotes
- The exercise of options to purchase an aggregate of 88,928 shares of common stock of the issuer and the sale of such shares of common stock were in each case effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2009.
- This transaction was executed in multiple trades at prices ranging from $42.78 to $43.26. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the reported transactions were effected.
- The stock option became fully vested and exercisable as of September 1, 2005.
- The stock option became fully vested and exercisable as of June 1, 2006.
- The stock option became fully vested and exercisable as of August 17, 2004.
- The stock option became fully vested and exercisable as of August 15, 2007.
Billionaire Hedge Funds
